A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Ark Investment Management LLC holds 189,606,908 shares of DNA stock, worth $154 Million. This represents 1.57% of its overall portfolio holdings.

Number of Shares
189,606,908
Previous 198,606,619 4.53%
Holding current value
$154 Million
Previous $336 Million 34.47%
% of portfolio
1.57%
Previous 2.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

SELL
$1.06 - $1.67 $9.54 Million - $15 Million
-8,999,711 Reduced 4.53%
189,606,908 $220 Million
Q4 2023

Jan 17, 2024

BUY
$1.26 - $1.79 $20.7 Million - $29.4 Million
16,414,434 Added 9.01%
198,606,619 $336 Million
Q3 2023

Oct 18, 2023

BUY
$1.61 - $2.54 $20 Million - $31.6 Million
12,442,658 Added 7.33%
182,192,185 $330 Million
Q2 2023

Jul 10, 2023

BUY
$1.14 - $1.95 $5.69 Million - $9.74 Million
4,992,542 Added 3.03%
169,749,527 $316 Million
Q1 2023

Apr 17, 2023

BUY
$1.2 - $2.19 $24.4 Million - $44.6 Million
20,372,918 Added 14.11%
164,756,985 $219 Million
Q4 2022

Jan 24, 2023

BUY
$1.63 - $3.52 $28.6 Million - $61.8 Million
17,565,211 Added 13.85%
144,384,067 $0
Q3 2022

Oct 17, 2022

BUY
$0.73 - $3.74 $28.8 Million - $148 Million
39,460,799 Added 45.17%
126,818,856 $396 Million
Q2 2022

Jul 11, 2022

BUY
$2.2 - $4.2 $50.2 Million - $95.9 Million
22,824,417 Added 35.37%
87,358,057 $269 Million
Q1 2022

Apr 19, 2022

BUY
$2.83 - $8.69 $60.4 Million - $186 Million
21,352,820 Added 49.45%
64,533,640 $260 Million
Q4 2021

Jan 28, 2022

BUY
$8.31 - $14.92 $166 Million - $298 Million
19,949,965 Added 85.88%
43,180,820 $359 Million
Q3 2021

Nov 12, 2021

BUY
$9.15 - $13.28 $213 Million - $309 Million
23,230,855 New
23,230,855 $269 Million

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $1.04B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track Cathie Wood's Portfolio

Track Cathie Wood Portfolio

Follow Cathie Wood (Ark Investment Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.